Literature DB >> 23778300

Simple Enterographic Activity Score for Crohn's Disease: comparison with endoscopic, biochemical, and clinical findings.

Piotr Eder, Katarzyna Katulska, Liliana Lykowska-Szuber, Kamila Stawczyk-Eder, Iwona Krela-Kaźmierczak, Krzysztof Linke.   

Abstract

INTRODUCTION: Magnetic resonance enterography (MRE) is believed to be a reliable diagnostic method in assessing the activity of small-bowel Crohn's disease (CD). However, there are no scales for quantifying MRE scores that could be used in everyday clinical practice.
OBJECTIVES: The aim of the study was to construct a simple scale for assessing the activity of CD (Simple Enterographic Activity Score for Crohn's Disease - SEAS-CD) in MRE and to investigate its clinical usefulness. PATIENTS AND METHODS: We conducted a retrospective analysis of MRE findings in 122 patients with CD. Disease activity was assessed using the SEAS-CD. The reference standard was endoscopic assessment using the Simple Endoscopic Score for Crohn's Disease (SES-CD). We assessed correlations between SEAS-CD and endoscopic, clinical, and biochemical findings. We also proposed the Global Crohn's Disease Activity Score to assess total CD activity by summarizing the colonic SES-CD and SEAS-CD scores.
RESULTS: In the validation group (n = 62), a significant correlation between the ileal SES-CD and ileal SEAS-CD scores was noted (r = 0.72, P <0.0001). In patients with isolated small-bowel CD, there was a significant correlation between SEAS-CD and Crohn's Disease Activity Index (CDAI), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), hemoglobin (Hb), albumin, and platelet count. In patients with ileocolonic CD, the Global Crohn's Disease Activity Score correlated with CDAI, CRP, ESR, Hb, and hematocrit.
CONCLUSIONS: SEAS-CD is a useful tool for the quantification of small-bowel CD activity assessed by MRE. The Global Crohn's Disease Activity Score may be useful in assessing the progression of lesions in patients with ileocolonic CD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23778300     DOI: 10.20452/pamw.1825

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  6 in total

1.  Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn's disease treated with anti-tumor necrosis factor antibodies.

Authors:  Piotr Eder; Michal Michalak; Katarzyna Katulska; Liliana Lykowska-Szuber; Iwona Krela-Kazmierczak; Kamila Stawczyk-Eder; Katarzyna Klimczak; Aleksandra Szymczak; Krzysztof Linke
Journal:  Sci Rep       Date:  2015-05-20       Impact factor: 4.379

2.  The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity.

Authors:  Piotr Eder; Katarzyna Katulska; Iwona Krela-Kaźmierczak; Kamila Stawczyk-Eder; Katarzyna Klimczak; Aleksandra Szymczak; Krzysztof Linke; Liliana Łykowska-Szuber
Journal:  Abdom Imaging       Date:  2015-10

3.  Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative study.

Authors:  Kamila Stawczyk-Eder; Piotr Eder; Liliana Lykowska-Szuber; Iwona Krela-Kazmierczak; Katarzyna Klimczak; Aleksandra Szymczak; Patrycja Szachta; Katarzyna Katulska; Krzysztof Linke
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

4.  Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn's disease naive to anti-TNF agents.

Authors:  Piotr Eder; Liliana Łykowska-Szuber; Katarzyna Katulska; Kamila Stawczyk-Eder; Iwona Krela-Kaźmierczak; Katarzyna Klimczak; Aleksandra Szymczak; Marek Stajgis; Krzysztof Linke
Journal:  Prz Gastroenterol       Date:  2015-11-04

Review 5.  A review of magnetic resonance enterography-based indices for quantification of Crohn's disease inflammation.

Authors:  Noa Rozendorn; Marianne Michal Amitai; Rami Abraham Eliakim; Uri Kopylov; Eyal Klang
Journal:  Therap Adv Gastroenterol       Date:  2018-04-13       Impact factor: 4.409

Review 6.  Implementation of the simple endoscopic activity score in crohn's disease.

Authors:  Efstratios Koutroumpakis; Konstantinos H Katsanos
Journal:  Saudi J Gastroenterol       Date:  2016 May-Jun       Impact factor: 2.485

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.